C-13 Metabolic Flux Analysis of Escherichia coli Engineered for Gamma-Aminobutyrate Production
- Authors
- Im, Dae-Kyun; Hong, Jaeseung; Gu, Boncheol; Sung, Changmin; Oh, Min-Kyu
- Issue Date
- 6월-2020
- Publisher
- WILEY-V C H VERLAG GMBH
- Keywords
- gamma-aminobutyrate; metabolic engineering; tricarboxylic acid cycle; C-13 metabolic flux analysis
- Citation
- BIOTECHNOLOGY JOURNAL, v.15, no.6
- Indexed
- SCIE
SCOPUS
- Journal Title
- BIOTECHNOLOGY JOURNAL
- Volume
- 15
- Number
- 6
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/55534
- DOI
- 10.1002/biot.201900346
- ISSN
- 1860-6768
- Abstract
- Escherichia coli is engineered for gamma-aminobutyrate (GABA) production in glucose minimal medium. For this, overexpression of mutant glutamate decarboxylase (GadB) and mutant glutamate/GABA antiporter (GadC), as well as deletion of GABA transaminase (GabT), are accomplished. In addition, the carbon flux to the tricarboxylic acid cycle is engineered by the overexpression of gltA, ppc, or both. The overexpression of citrate synthase (CS), encoded by gltA, increases GABA productivity, as expected. Meanwhile, the overexpression of phosphoenolpyruvate carboxylase (PPC) causes a decrease in the rate of glucose uptake, resulting in a decrease in GABA production. The phenotypes of the strains are characterized by C-13 metabolic flux analysis (C-13 MFA). The results reveal that CS overexpression increases glycolysis and anaplerotic reaction rates, as well as the citrate synthesis rate, while PPC overexpression causes little changes in metabolic fluxes, but reduces glucose uptake rate. The engineered strain produces 1.2 g L-1 of GABA from glucose. Thus, by using C-13 MFA, important information is obtained for designing metabolically engineered strains for efficient GABA production.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Engineering > Department of Chemical and Biological Engineering > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.